Topical Antifungals (e.g., Ketoconazole)

Type: drug

Status: FDA Approved

Developer: Janssen Pharmaceutica (original development), now generic

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026